Olivier E. Pardo

3.5k total citations
47 papers, 2.5k citations indexed

About

Olivier E. Pardo is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Olivier E. Pardo has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Cell Biology and 9 papers in Oncology. Recurrent topics in Olivier E. Pardo's work include PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). Olivier E. Pardo is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). Olivier E. Pardo collaborates with scholars based in United Kingdom, United States and Switzerland. Olivier E. Pardo's co-authors include Michael J. Seckl, Julian Downward, Romain Lara, Rajat Roy, Nicholas R. Lemoine, Patricia H. Warne, Alexandre Arcaro, Richard Poulsom, Ivan Gout and Francesco Mauri and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Olivier E. Pardo

43 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier E. Pardo United Kingdom 24 1.9k 561 552 546 369 47 2.5k
James Hulit United States 26 1.7k 0.9× 466 0.8× 596 1.1× 772 1.4× 155 0.4× 31 2.4k
Federico Gulluni Italy 16 1.5k 0.8× 475 0.8× 333 0.6× 342 0.6× 187 0.5× 19 2.1k
Barbara Belletti Italy 33 1.9k 1.0× 478 0.9× 925 1.7× 1.2k 2.1× 293 0.8× 91 3.0k
Nicole R. Murray United States 26 1.4k 0.8× 273 0.5× 381 0.7× 637 1.2× 211 0.6× 47 2.1k
Shuangxing Yu United States 27 2.7k 1.4× 639 1.1× 560 1.0× 436 0.8× 144 0.4× 33 3.2k
Xiangpeng Dai United States 20 1.5k 0.8× 325 0.6× 361 0.7× 838 1.5× 404 1.1× 29 2.2k
Hugh Arnold United States 15 2.0k 1.1× 278 0.5× 398 0.7× 797 1.5× 412 1.1× 18 2.7k
Anna C. Schinzel United States 21 2.3k 1.2× 511 0.9× 375 0.7× 738 1.4× 205 0.6× 39 3.1k
Eva Grönroos United Kingdom 21 1.5k 0.8× 393 0.7× 466 0.8× 571 1.0× 147 0.4× 29 2.2k
Jung-Sik Kim United States 26 1.5k 0.8× 232 0.4× 406 0.7× 596 1.1× 313 0.8× 45 2.2k

Countries citing papers authored by Olivier E. Pardo

Since Specialization
Citations

This map shows the geographic impact of Olivier E. Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier E. Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier E. Pardo more than expected).

Fields of papers citing papers by Olivier E. Pardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier E. Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier E. Pardo. The network helps show where Olivier E. Pardo may publish in the future.

Co-authorship network of co-authors of Olivier E. Pardo

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier E. Pardo. A scholar is included among the top collaborators of Olivier E. Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier E. Pardo. Olivier E. Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cazenave, Tristan, et al.. (2024). DrugSynthMC: An Atom-Based Generation of Drug-like Molecules with Monte Carlo Search. Journal of Chemical Information and Modeling. 64(18). 7097–7107.
2.
Bdzhola, Volodymyr G., Olivier E. Pardo, Michael J. Seckl, et al.. (2024). Investigating the Regulation of Ribosomal Protein S6 Kinase 1 by CoAlation. International Journal of Molecular Sciences. 25(16). 8747–8747. 2 indexed citations
3.
Khalil, Mahmoud, Heba Ismail, Ganna Panasyuk, et al.. (2023). Asymmetric Dimethylation of Ribosomal S6 Kinase 2 Regulates Its Cellular Localisation and Pro-Survival Function. International Journal of Molecular Sciences. 24(10). 8806–8806. 2 indexed citations
4.
Roy, Rajat K., Jennifer Doig, Lukáš Krásný, et al.. (2023). Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell Death and Disease. 14(11). 725–725. 6 indexed citations
5.
Roy, Rajat, Geoffrey J. Maher, Paul Ajuh, et al.. (2022). ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene. 41(18). 2540–2554. 11 indexed citations
6.
Zhang, Congcong, et al.. (2019). Mechanisms Underlying Chemoresistance of Choriocarcinoma Investigated with NMR-Based Metabonomics. SHILAP Revista de lepidopterología. 1 indexed citations
7.
O′Flaherty, Linda, Steven D. Shnyder, Patricia A. Cooper, et al.. (2019). Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer. PLoS ONE. 14(4). e0214610–e0214610. 20 indexed citations
8.
Wang, Xiaomeng, Christiaan F. Labuschagne, David Y. Mason, et al.. (2017). Oncogene-Selective Sensitivity to Synchronous Cell Death following Modulation of the Amino Acid Nutrient Cystine. Cell Reports. 18(11). 2547–2556. 206 indexed citations
9.
Li, Hongde, Rajat Roy, Elza de Bruin, et al.. (2016). Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer. Cell Discovery. 2(1). 16031–16031. 28 indexed citations
10.
Pardo, Olivier E. & Michael J. Seckl. (2013). S6K2: The Neglected S6 Kinase Family Member. Frontiers in Oncology. 3. 191–191. 54 indexed citations
11.
Lara, Romain, Francesco Mauri, Rita Derua, et al.. (2011). An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. Oncogene. 30(32). 3513–3521. 78 indexed citations
12.
Laurentiis, Angela De, Olivier E. Pardo, Andrea Palamidessi, et al.. (2010). The catalytic class IA PI3K isoforms play divergent roles in breast cancer cell migration. Cellular Signalling. 23(3). 529–541. 6 indexed citations
13.
Pardo, Olivier E., John Latigo, Rosemary Jeffery, et al.. (2009). The Fibroblast Growth Factor Receptor Inhibitor PD173074 Blocks Small Cell Lung Cancer Growth In vitro and In vivo. Cancer Research. 69(22). 8645–8651. 134 indexed citations
14.
Marinov, Marin, Algirdas Ziogas, Olivier E. Pardo, et al.. (2009). AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001. Clinical Cancer Research. 15(4). 1277–1287. 79 indexed citations
15.
Yuan, Ming, Romain Lara, Deborah L. Holliday, et al.. (2008). Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death and Differentiation. 15(11). 1752–1759. 271 indexed citations
16.
Swanton, Charles, Michela Marani, Olivier E. Pardo, et al.. (2007). Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs. Cancer Cell. 11(6). 498–512. 307 indexed citations
17.
Pardo, Olivier E., Claudia Wellbrock, Muriel Aubert, et al.. (2006). FGF‐2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B‐Raf and S6K2. The EMBO Journal. 25(13). 3078–3088. 144 indexed citations
18.
Michl, Patrick, Antoine R. Ramjaun, Olivier E. Pardo, et al.. (2005). CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness. Cancer Cell. 7(6). 521–532. 135 indexed citations
19.
Pardo, Olivier E., Alexandre Arcaro, Giovanni Salerno, et al.. (2001). Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells. Oncogene. 20(52). 7658–7667. 64 indexed citations
20.
Pardo, Olivier E., Julia Colston, & Katalin Lukács. (1998). Cancer Gene Therapy with a Heat Shock Protein Gene. Advances in experimental medicine and biology. 451. 217–223. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Hulit Breakdown of academic impact, for papers by Federico Gulluni Breakdown of academic impact, for papers by Barbara Belletti Breakdown of academic impact, for papers by Nicole R. Murray Breakdown of academic impact, for papers by Shuangxing Yu Breakdown of academic impact, for papers by Xiangpeng Dai Breakdown of academic impact, for papers by Hugh Arnold Breakdown of academic impact, for papers by Anna C. Schinzel Breakdown of academic impact, for papers by Eva Grönroos Breakdown of academic impact, for papers by Jung-Sik Kim
Rankless by CCL
2026